US FDA approves Pfizer’s Biosimilar Zirabev
Pfizer Inc announced the US FDA has approved Zirabev (bevacizumab-bvzr), a biosimilar to Avastin (bevacizumab), for the treatment of five types of... Read More
USFDA approval of Avastin biosimilar Mvasi
Posted on16 Sep 2017
Comments0
The USFDA is approved a version of Avastin, a blockbuster chemotherapy made by Genentech that brought in $6.7 billion in sales in... Read More
Top 5 global pharmaceutical brands by sales
Observations: All top 5 pharmaceutical brands are biopharma products Harvoni approved by USFDA on Oct 10, 2014. It is one of the... Read More